vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and InvenTrust Properties Corp. (IVT). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $77.4M, roughly 1.1× InvenTrust Properties Corp.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 3.4%, a 19.4% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 8.6%). InvenTrust Properties Corp. produced more free cash flow last quarter ($110.9M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 7.6%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
InvenTrust Properties Corp. is a real estate investment trust that invests in shopping malls. As of December 31, 2024, the company owned interests in 68 properties comprising 11.0 million square feet.
FDMT vs IVT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $77.4M |
| Net Profit | $19.4M | $2.7M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | -11.0% |
| Net Margin | 22.8% | 3.4% |
| Revenue YoY | 8508900.0% | 8.6% |
| Net Profit YoY | 139.1% | -72.8% |
| EPS (diluted) | $0.43 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $77.4M | ||
| Q3 25 | $90.0K | $74.5M | ||
| Q2 25 | $15.0K | $73.6M | ||
| Q1 25 | $14.0K | $73.8M | ||
| Q4 24 | $1.0K | $71.2M | ||
| Q3 24 | $3.0K | $68.5M | ||
| Q2 24 | $5.0K | $67.4M | ||
| Q1 24 | $28.0K | $66.8M |
| Q4 25 | $19.4M | $2.7M | ||
| Q3 25 | $-56.9M | $6.0M | ||
| Q2 25 | $-54.7M | $95.9M | ||
| Q1 25 | $-48.0M | $6.8M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | $-43.8M | $-539.0K | ||
| Q2 24 | $-35.0M | $1.5M | ||
| Q1 24 | $-32.4M | $2.9M |
| Q4 25 | 17.3% | -11.0% | ||
| Q3 25 | -67983.3% | -9.8% | ||
| Q2 25 | -396373.3% | — | ||
| Q1 25 | -383007.1% | -10.5% | ||
| Q4 24 | — | -3.6% | ||
| Q3 24 | -1704400.0% | -18.7% | ||
| Q2 24 | -849120.0% | -13.6% | ||
| Q1 24 | -136200.0% | -13.1% |
| Q4 25 | 22.8% | 3.4% | ||
| Q3 25 | -63195.6% | 8.1% | ||
| Q2 25 | -364386.7% | 130.4% | ||
| Q1 25 | -342657.1% | 9.2% | ||
| Q4 24 | — | 13.8% | ||
| Q3 24 | -1461433.3% | -0.8% | ||
| Q2 24 | -699060.0% | 2.2% | ||
| Q1 24 | -115717.9% | 4.3% |
| Q4 25 | $0.43 | $0.02 | ||
| Q3 25 | $-1.01 | $0.08 | ||
| Q2 25 | $-0.98 | $1.23 | ||
| Q1 25 | $-0.86 | $0.09 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | $-0.79 | $-0.01 | ||
| Q2 24 | $-0.63 | $0.02 | ||
| Q1 24 | $-0.66 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | — |
| Total DebtLower is stronger | — | $825.9M |
| Stockholders' EquityBook value | $505.7M | $1.8B |
| Total Assets | $566.7M | $2.8B |
| Debt / EquityLower = less leverage | — | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | — | ||
| Q3 25 | $305.1M | — | ||
| Q2 25 | $293.2M | — | ||
| Q1 25 | $321.4M | — | ||
| Q4 24 | $424.9M | — | ||
| Q3 24 | $501.9M | — | ||
| Q2 24 | $541.9M | — | ||
| Q1 24 | $525.9M | — |
| Q4 25 | — | $825.9M | ||
| Q3 25 | — | $764.6M | ||
| Q2 25 | — | $746.3M | ||
| Q1 25 | — | $740.7M | ||
| Q4 24 | — | $740.4M | ||
| Q3 24 | — | $740.1M | ||
| Q2 24 | — | $812.2M | ||
| Q1 24 | — | $827.5M |
| Q4 25 | $505.7M | $1.8B | ||
| Q3 25 | $369.0M | $1.8B | ||
| Q2 25 | $420.9M | $1.8B | ||
| Q1 25 | $469.7M | $1.7B | ||
| Q4 24 | $510.6M | $1.8B | ||
| Q3 24 | $552.9M | $1.8B | ||
| Q2 24 | $588.3M | $1.5B | ||
| Q1 24 | $600.6M | $1.5B |
| Q4 25 | $566.7M | $2.8B | ||
| Q3 25 | $424.0M | $2.7B | ||
| Q2 25 | $473.6M | $2.7B | ||
| Q1 25 | $515.7M | $2.6B | ||
| Q4 24 | $560.4M | $2.6B | ||
| Q3 24 | $604.0M | $2.6B | ||
| Q2 24 | $620.1M | $2.5B | ||
| Q1 24 | $629.9M | $2.5B |
| Q4 25 | — | 0.46× | ||
| Q3 25 | — | 0.42× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 0.42× | ||
| Q4 24 | — | 0.42× | ||
| Q3 24 | — | 0.42× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $155.4M |
| Free Cash FlowOCF − Capex | $28.5M | $110.9M |
| FCF MarginFCF / Revenue | 33.5% | 143.3% |
| Capex IntensityCapex / Revenue | 0.1% | 57.5% |
| Cash ConversionOCF / Net Profit | 1.47× | 58.41× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $193.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $155.4M | ||
| Q3 25 | $-46.5M | $43.8M | ||
| Q2 25 | $-43.4M | $48.7M | ||
| Q1 25 | $-47.8M | $20.2M | ||
| Q4 24 | $-134.6M | $136.9M | ||
| Q3 24 | $-29.4M | $38.4M | ||
| Q2 24 | $-30.2M | $46.7M | ||
| Q1 24 | $-29.1M | $14.8M |
| Q4 25 | $28.5M | $110.9M | ||
| Q3 25 | $-46.6M | $31.4M | ||
| Q2 25 | $-43.4M | $38.0M | ||
| Q1 25 | $-48.4M | $12.8M | ||
| Q4 24 | $-138.4M | $100.8M | ||
| Q3 24 | $-31.2M | $29.3M | ||
| Q2 24 | $-30.6M | $37.2M | ||
| Q1 24 | $-29.8M | $7.7M |
| Q4 25 | 33.5% | 143.3% | ||
| Q3 25 | -51765.6% | 42.2% | ||
| Q2 25 | -289620.0% | 51.6% | ||
| Q1 25 | -345635.7% | 17.4% | ||
| Q4 24 | -13837100.0% | 141.5% | ||
| Q3 24 | -1038966.7% | 42.8% | ||
| Q2 24 | -611840.0% | 55.2% | ||
| Q1 24 | -106421.4% | 11.5% |
| Q4 25 | 0.1% | 57.5% | ||
| Q3 25 | 101.1% | 16.7% | ||
| Q2 25 | 440.0% | 14.6% | ||
| Q1 25 | 4507.1% | 10.0% | ||
| Q4 24 | 378600.0% | 50.7% | ||
| Q3 24 | 59266.7% | 13.3% | ||
| Q2 24 | 6980.0% | 14.0% | ||
| Q1 24 | 2535.7% | 10.6% |
| Q4 25 | 1.47× | 58.41× | ||
| Q3 25 | — | 7.27× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 2.97× | ||
| Q4 24 | — | 13.97× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 31.15× | ||
| Q1 24 | — | 5.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
